125 related articles for article (PubMed ID: 37977349)
1. Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis.
Qin Y; Xiong S; Ren J; Sethi G
Cancer Lett; 2024 Jan; 580():216482. PubMed ID: 37977349
[TBL] [Abstract][Full Text] [Related]
2. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
Huang S; Qi P; Zhang T; Li F; He X
Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
[TBL] [Abstract][Full Text] [Related]
3. MiR-200c-based metabolic modulation in glioblastoma cells as a strategy to overcome tumor chemoresistance.
Cardoso AM; Morais CM; Sousa M; Rebelo O; Tão H; Barbosa M; Pedroso de Lima MC; Jurado AS
Hum Mol Genet; 2021 Nov; 30(23):2315-2331. PubMed ID: 34245265
[TBL] [Abstract][Full Text] [Related]
4. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response.
Hombach-Klonisch S; Mehrpour M; Shojaei S; Harlos C; Pitz M; Hamai A; Siemianowicz K; Likus W; Wiechec E; Toyota BD; Hoshyar R; Seyfoori A; Sepehri Z; Ande SR; Khadem F; Akbari M; Gorman AM; Samali A; Klonisch T; Ghavami S
Pharmacol Ther; 2018 Apr; 184():13-41. PubMed ID: 29080702
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
Forte IM; Indovina P; Iannuzzi CA; Cirillo D; Di Marzo D; Barone D; Capone F; Pentimalli F; Giordano A
Int J Oncol; 2019 Jun; 54(6):2189-2199. PubMed ID: 31081046
[TBL] [Abstract][Full Text] [Related]
6. Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.
Martell E; Kuzmychova H; Senthil H; Kaul E; Chokshi CR; Venugopal C; Anderson CM; Singh SK; Sharif T
Acta Neuropathol Commun; 2023 Jul; 11(1):110. PubMed ID: 37420311
[TBL] [Abstract][Full Text] [Related]
7. The DRD2 Antagonist Haloperidol Mediates Autophagy-Induced Ferroptosis to Increase Temozolomide Sensitivity by Promoting Endoplasmic Reticulum Stress in Glioblastoma.
Shi L; Chen H; Chen K; Zhong C; Song C; Huang Y; Wang T; Chen L; Li C; Huang A; Qi S; Li H; Lu Y
Clin Cancer Res; 2023 Aug; 29(16):3172-3188. PubMed ID: 37249604
[TBL] [Abstract][Full Text] [Related]
8. Autophagy inhibition potentiates SAHA‑mediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria.
Lohitesh K; Saini H; Srivastava A; Mukherjee S; Roy A; Chowdhury R
Oncol Rep; 2018 Jun; 39(6):2787-2796. PubMed ID: 29658588
[TBL] [Abstract][Full Text] [Related]
9. TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma.
Yu J; Gao G; Wei X; Wang Y
BMC Cancer; 2022 Jul; 22(1):786. PubMed ID: 35850753
[TBL] [Abstract][Full Text] [Related]
10. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma.
Taylor MA; Das BC; Ray SK
Apoptosis; 2018 Dec; 23(11-12):563-575. PubMed ID: 30171377
[TBL] [Abstract][Full Text] [Related]
11. Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells.
Momeny M; Shamsaiegahkani S; Kashani B; Hamzehlou S; Esmaeili F; Yousefi H; Irani S; Mousavi SA; Ghaffari SH
Life Sci; 2021 Dec; 287():120100. PubMed ID: 34715143
[TBL] [Abstract][Full Text] [Related]
12. A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy.
Noack J; Choi J; Richter K; Kopp-Schneider A; Régnier-Vigouroux A
Cell Death Dis; 2014 Sep; 5(9):e1425. PubMed ID: 25255218
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis.
Buccarelli M; Marconi M; Pacioni S; De Pascalis I; D'Alessandris QG; Martini M; Ascione B; Malorni W; Larocca LM; Pallini R; Ricci-Vitiani L; Matarrese P
Cell Death Dis; 2018 Aug; 9(8):841. PubMed ID: 30082680
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
15. Promising potential of boron compounds against Glioblastoma: In Vitro antioxidant, anti-inflammatory and anticancer studies.
Turkez H; Arslan ME; Tatar A; Mardinoglu A
Neurochem Int; 2021 Oct; 149():105137. PubMed ID: 34293392
[TBL] [Abstract][Full Text] [Related]
16. Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness.
Su YK; Lin JW; Shih JW; Chuang HY; Fong IH; Yeh CT; Lin CM
Cells; 2020 Aug; 9(8):. PubMed ID: 32784466
[No Abstract] [Full Text] [Related]
17. HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
Li H; Li J; Chen L; Qi S; Yu S; Weng Z; Hu Z; Zhou Q; Xin Z; Shi L; Ma L; Huang A; Lu Y
Clin Cancer Res; 2019 Jun; 25(12):3602-3616. PubMed ID: 30862693
[TBL] [Abstract][Full Text] [Related]
18. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization.
Li Z; Fu WJ; Chen XQ; Wang S; Deng RS; Tang XP; Yang KD; Niu Q; Zhou H; Li QR; Lin Y; Liang M; Li SS; Ping YF; Liu XD; Bian XW; Yao XH
J Exp Clin Cancer Res; 2022 Feb; 41(1):74. PubMed ID: 35193644
[TBL] [Abstract][Full Text] [Related]
19. MiR-144 overexpression as a promising therapeutic strategy to overcome glioblastoma cell invasiveness and resistance to chemotherapy.
Cardoso AMS; Sousa M; Morais CM; Oancea-Castillo LR; Régnier-Vigouroux A; Rebelo O; Tão H; Barbosa M; Pedroso MCL; Jurado AS
Hum Mol Genet; 2019 Aug; 28(16):2738-2751. PubMed ID: 31087038
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma ablates pericytes antitumor immune function through aberrant up-regulation of chaperone-mediated autophagy.
Valdor R; García-Bernal D; Riquelme D; Martinez CM; Moraleda JM; Cuervo AM; Macian F; Martinez S
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20655-20665. PubMed ID: 31548426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
